Telmiviti Trio 12.5
Telmisartan + Cilnidipine + Chlorthalidone
Prescribed in cardiovascular care as directed by the treating physician.
Each tablet contains Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg).
Manufactured at Graviti's oral solid dosage facility under validated processes, with in-process content uniformity checks and release testing against approved specifications.
This information is intended for healthcare professionals and trade partners. The brand name applies to Graviti's own branded generics range in India; in other markets the same formulation is supplied as a generic under our filings or a partner label. Prescribing information, registration status and pack availability vary by market. Medicines should be used only under qualified medical supervision.
Telmiviti Trio 12.5 — made to the same standard as every Graviti batch.